Dr Jeffery Huang (third from left), Professor Ken Yung (fourth from left), Professor Bian Zhaoxiang (fifth from left), Professor Cheung Yiu-ming (fifth from right), Dr Ren Kangning (six from right), with HKBU Vice-President (Research and Development) Professor Rick Wong (seventh from right) and Head of Knowledge Transfer Office Dr Alfred Tan (third from right)
HKBU teams win top awards at International Exhibition of Inventions of Geneva
A delegation from Hong Kong Baptist University (HKBU) won top prizes, including three Gold Medals with Congratulations of Jury, one Gold Medal, and an award of excellence from Romania, at the 46th International Exhibition of Inventions of Geneva held in Switzerland from 11 to 14 April 2018.
HKBU is the only institution in Hong Kong that all the projects it submitted won gold medals in three consecutive years.
HKBU submitted four entries this year. The winning projects are:
-- “Lead Detecting Device for Water” invented by Dr Ren Kangning, Assistant Professor, and Dr Edmond Ma, Associate Professor, of the Department of Chemistry, which won a Gold Medal.
-- “Lip-password: Double Security System for Identity Authentication” invented by Professor Cheung Yiu-ming of the Department of Computer Science, which won a Gold Medals with Congratulations of Jury.
-- “Medical Devices for Stem Cell Therapy” invented by Professor Ken Yung of the Department of Biology and Dr Jeffery Huang, Assistant Professor of the Department of Physics, which won a Gold Medals with Congratulations of Jury.
-- “Treatment for Irritable Bowel Syndrome (IBS) Diseases” invented by Professor Bian Zhaoxiang, Tsang Shiu Tim Endowed Chair of Chinese Medicine Clinical Studies of the School of Chinese Medicine, which won a Gold Medals with Congratulations of Jury.
Extending his hearty congratulations to the winning teams, HKBU President Professor Roland Chin said: "These award-winning inventions are the pride of not just HKBU but of Hong Kong as a whole. Our achievement and creativity won accolades from international experts because they are of high social impact and have brought amazing solutions to real-world problems."
The “Lead Detecting Device for Water” invented by Dr Ren Kangning and Dr Edmond Ma is a 10-minute on-site lead detection method using a portable, DNA-based paper device. The device is very simple and designed for on-site lead testing in drinking water without the need of special training or skills. Easy to operate, quick and accurate detection and low cost are key features of the device.
The “Lip-password: Double Security System for Identity Authentication” invented by Professor Cheung Yiu-ming introduces a new technique, which utilises a person’s lip motions to create a password. This system verifies a person’s identity by simultaneously matching the password content with the underlying behavioural characteristics of lip movement. Its uniqueness includes double-security for access control, resistant to mimicry and has no language boundary. It can be used in financial transaction authentication or used together with other biometrics to enhance the security level of systems.
The “Treatment for Irritable Bowel Syndrome (IBS) Diseases” is developed by Professor Bian Zhaoxiang in collaboration with the Chinese University of Hong Kong. The team took reference from the traditional Chinese “diarrhoea formula” and revised it into a new formula for treating IBS-D. Through clinical studies, the drug showed that it is effective in curing visceral pain, torso pain and diarrhea, and patients found their symptoms improved after taking the medicine for eight consecutive weeks with no recurrence of symptoms. The patent rights are exclusively licensed to PuraPharm Corporation Limited, and a large scale of clinical trial approved by the China Food and Drug Administration will be conducted in Mainland China and Hong Kong.
The “Medical Devices for Stem Cell Therapy” invented by Professor Ken Yung and Dr Jeffery Huang introduces inorganic sculptured extracellular nanomatrices (iSECnMs), made of biocompatible materials and sculpturable structures to avoid using animal or any other biochemical growth factor for cultivating cells. The research found the device is of high bio-safety and is suitable for mass production with low cost. It is hoped that it will help extract the patient’s neural stem cells and turn them into the therapeutic agent for curing many incurable diseases such as neurodegenerative diseases, chronic systemic diseases and degenerative joint diseases.